SIG
52
5
AFL
34
6
SO
48
6
RL
73
5
MO
47
6
BDX
59
3
TMO
52
8
ALL
37
3
T
32
2
LMT
29
-5
MAS
46
3
KR
50
5
SLB
41
2
MCO
67
3
SBUX
29
-2
NVDA
52
5
IBM
53
2
MHK
25
5
L
54
5
BEN
36
4
SIG
52
5
AFL
34
6
SO
48
6
RL
73
5
MO
47
6
BDX
59
3
TMO
52
8
ALL
37
3
T
32
2
LMT
29
-5
MAS
46
3
KR
50
5
SLB
41
2
MCO
67
3
SBUX
29
-2
NVDA
52
5
IBM
53
2
MHK
25
5
L
54
5
BEN
36
4
Financhill
Back

Purple Innovation 10K Form

Sell
30

PRPL
Purple Innovation

Last Price:
$0.91
Seasonality Move:
-5.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRPL News And Ratings

See the #1 stock for the next 7 days that we like better than PRPL

PRPL Financial Statistics

Sales & Book Value

Annual Sales: $510.5M
Cash Flow: $-9K
Price / Cash Flow: 0
Annual Sales: $0.26
Price / Book: 3.49

Profitability

EPS (TTM): -1.01010
Net Income (TTM): $-107.8M
Gross Margin: $171.8M
Return on Equity: -131.76%
Return on Assets: -29.25%

Purple Innovation Earnings Forecast

Key Purple Innovation Financial Ratios

  • The Gross Profit Margin over the past 7 years for PRPL is 33.66%.
  • The Selling, General & Administrative Expenses for PRPL have been equal to 52.25% of Gross Profit Margin.
  • The Research & Development expenses have been 2.33% of Revenue.
  • The Interest Expense is -1.63% of Operating Income.
  • The Net Earning history of PRPL is -23.65% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

Purple Innovation Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Household Durables
Sector: Consumer Discretionary
Current Symbol: PRPL
CUSIP: 74640Y
Website: purple.com

Debt

Debt-to-Equity Ratio: 1.82
Current Ratio: 1.3
Quick Ratio: 0.56

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRPL Technical Analysis vs Fundamental Analysis

Sell
30
Purple Innovation (PRPL) is a Sell

Is Purple Innovation a Buy or a Sell?

  • Purple Innovation stock is rated a Sell
    The current Purple Innovation [PRPL] share price is $0.91. The Score for PRPL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.